NCT00664573终止2 期
Assessment of Safety and Efficacy of BG9924 in Subjects With RA Who Have Participated in Study 104RA202.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 发起方
- Biogen
- 入组人数
- 339
- 试验地点
- 9
- 主要终点
- To Observe The Long-Term treatment with BG9924 When Administered to Participants with RA who Previously Participated in a Biogen Idec Study
研究概览
简要总结
To observe the long-term treatment with BG9924 when administered to participants with RA who previously participated in a Biogen Idec Study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Must be a participant from Study 104RA202 (NCT 00664716)
- •Stable dose of Methotrexate for the duration of the study
排除标准
- •Participants with a significant change in their medical history from their previous BG9924 study
- •Any clinically significant infectious illness or serious local infection
- •NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.
结局指标
主要结局
To Observe The Long-Term treatment with BG9924 When Administered to Participants with RA who Previously Participated in a Biogen Idec Study
时间窗: Duration of this study is 18 months
次要结局
未报告次要终点
研究者
研究点 (9)
Loading locations...
相似试验
已完成
2 期
Assessment Of The Safety And Efficacy Of BG9924 In Rheumatoid Arthritis (RA) ParticipantsRheumatoid ArthritisNCT00664716Biogen391
已完成
2 期
Long-Term Assessment of Safety and Physical Function With AMG 108 in RARheumatoid ArthritisNCT00369473Amgen690
已完成
1 期
Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate BackgroundRheumatoid ArthritisNCT00162292Bristol-Myers Squibb33
未知
2 期
Phase IIa study of T-5224 in RA patientsRheumatoid ArthritisJPRN-jRCT2080221322Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)
已完成
2 期
Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid ArthritisRheumatoid ArthritisNCT00810836Biogen153